SCHEMBL2993952

SCHEMBL2993952

O=C(O)c1cc2c(C3CCCCC3)c(-c3ccccc3)[nH]c2s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.43
CDK2 P24941 2/20 0.43
CCNA2 P20248 1/20 0.43
PLK1 P53350 1/20 0.43
CCNA1 P78396 1/20 0.43
PLK4 O00444 2/20 0.41
DAPK3 O43293 2/20 0.41
CHEK2 O96017 2/20 0.41
CDK1 P06493 2/20 0.41
PIM1 P11309 2/20 0.41
MAPK9 P45984 2/20 0.41
GSK3B P49841 2/20 0.41
DYRK1A Q13627 2/20 0.41
AURKB Q96GD4 2/20 0.41
PLK3 Q9H4B4 2/20 0.41
SGK2 Q9HBY8 2/20 0.41
PDPK1 O15530 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
RET P07949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995571 0.85 KDM4E (0.42) KDRCDK2CCNA2PLK1CCNA1
SCHEMBL5231212 0.82 HTR2A (0.39) KDRCDK2CCNA2PLK1CCNA1
SCHEMBL2995670 0.81 HTR2A (0.42) KDRCDK2CCNA2PLK1CCNA1
SCHEMBL2995376 0.80 HTR2A (0.43) KDRCDK2CCNA2PLK1CCNA1
SCHEMBL2993953 0.76 KDM4E (0.49) CDK2PLK4DAPK3CHEK2CDK1
SCHEMBL1173816 0.74 PARP1 (0.52) HTR2AKCNH2HTR2CDRD2
SCHEMBL2987900 0.72 HTR2A (0.39) KDRCDK2CCNA2PLK1CCNA1
SCHEMBL13211532 0.71 PTGS1 (0.46) MAPK9HTR2AKCNH2HTR2CDRD2
SCHEMBL2997440 0.71 GCGR (0.40) PRKAA1HTR2AKCNH2
SCHEMBL13211500 0.71 PLK4 (0.39) KDRCDK2PLK1PLK4DAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US claimed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP claimed
JP-2007505091-A 2007-03-08 JP claimed
CN-1849323-A Thienopyrroles as antiviral agents ANGELETTI P IST RICHERCHE BIO (IT) 2006-10-18 CN claimed
EP-1664059-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2006-06-07 EP claimed
WO-2005023819-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-03-17 WO claimed
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP disclosed
CN-1849323-A Thienopyrroles as antiviral agents ANGELETTI P IST RICHERCHE BIO (IT) 2006-10-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036443-A1 Thienopyrroles as antiviral agents ZC3HAV1, XDH, TPMT KDR 4513/4885CDK2 424/4885CCNA2 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.